InvestorsHub Logo

H2R

Followers 42
Posts 2159
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Saturday, 03/26/2022 6:25:07 PM

Saturday, March 26, 2022 6:25:07 PM

Post# of 863
BLA submission planned for Q1: a few days left

The March investor presentation kept the BLA submittal for Q1 2022:

"U.S. FDA BLA submission targeted for calendar Q1 2022 with anticipated
approval to follow 9-12 months later"



Slide 31
https://ir.outlooktherapeutics.com/static-files/11f87d8a-4a26-4798-97c6-f545a60870a1

I hope the April investor presentation has the good news, if not a PR, even better, with a PDUFA date set, before the end of April :) A bit optimistic but doable if they keep their dates.

Best of luck with your investments!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OTLK News